glp 1 microdosing for autoimmune The People v. GLP-1's Microdosing" GLP-1: case studies and

exendin-4 [714,715] and attenuates central GLP-1 effects on brown and inguinal white adipose tissue [666]

Access this article Similar content being viewed by others Abbreviations Anti-TNF: Anti-tumor necrosis factor- Anti-IL12 and anti-IL23: Anti-interleukin-12 and anti-interleukin-23 c-AMP: Cyclic adenosine monophosphate CD: Crohns disease CDAI: Crohns Disease Activity Index DNA: Deoxy-ribonucleic acid DPP-4: Dipeptidyl peptidase-4 EGF: Epidermal growth factor ESPEN: European Society for Clinical Nutrition and Metabolism GE: Gastric emptying GI: Gastrointestinal GLP-2: Glucagon-like peptide-2 GLP-2R: Glucagon-like peptide 2 receptor GIP: Glucose-dependent insulinotropic polypeptide GRPP: Glicentin-related pancreatic peptide IBD: Inflammatory bowel disease IGF-1: Insulin-like growth factor-1 IVS: Intravenous supplementation KGF: Keratinocyte growth factor nNOS: Neuronal nitric oxide synthase PC: Pro-hormone convertase PGDP: Pro-glucagon-derived peptide PKA: Protein kinase A PS: Parenteral support QoL: Quality of life SBS-IF: Short bowel syndrome-intestinal failure SC: Subcutaneous SGLT-1: Sodium-glucose transporter-1 T2DM: Diabetes mellitus type 2 References Papers of particular interest, published recently, have been highlighted as: Of importance Of major importance Seige K

Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes

Active lifestyle: Incorporating more movement that I genuinely enjoy, whether its walking, dancing, or light strength training, is crucial

doi:10.1001/jama.2023.19897